NewsBenzingaStandard BioTools Terminates Its Previously Announced Agreement To Sell Its Mass Cytometry Business To Multiplex Bio; Co. Enters Into A Definitive Agreement To Sell Its Mass Cytometry Business To Element Biosystems For $5.5M In Cash Payable Standard BioTools Terminates Its Previously Announced Agreement To Sell Its Mass Cytometry Business To Multiplex Bio; Co. Enters Into A Definitive Agreement To Sell Its Mass Cytometry Business To Element Biosystems For $5.5M In Cash Payable Benzinga 2026.09.30 20:45 (GMT+0) Open on Benzinga Other news Epic Games pushes "AI-first" development, requiring teams to use Claude and stop hand-writing code Navitas Semiconductor Announces 24 Kilowatts, 800 Volts To 12 12 V DC-DC GaNFast-Powered Power Delivery Board Developed In Partnership With Nvidia Here's How Much $1000 Invested In Cisco Systems 5 Years Ago Would Be Worth Today Northern Oil And Gas Reports Q3 Operational Activity, Expected Expected Capital Spending In The Range Of $250M-$253M Johnson & Johnson Announces Three-Year Data From Its Phase 3 GALAXI 2, 3 Trials Of TREMFYA Demonstrate Efficacy, Consistent Profile To Treat Crohn's Disease CORRECTION: Nurix Therapeutics Q3 EPS $4.73 Beats $3.98 Estimate, Sales $673.064M Beat $411.481M Estimate
Navitas Semiconductor Announces 24 Kilowatts, 800 Volts To 12 12 V DC-DC GaNFast-Powered Power Delivery Board Developed In Partnership With Nvidia
Northern Oil And Gas Reports Q3 Operational Activity, Expected Expected Capital Spending In The Range Of $250M-$253M
Johnson & Johnson Announces Three-Year Data From Its Phase 3 GALAXI 2, 3 Trials Of TREMFYA Demonstrate Efficacy, Consistent Profile To Treat Crohn's Disease
CORRECTION: Nurix Therapeutics Q3 EPS $4.73 Beats $3.98 Estimate, Sales $673.064M Beat $411.481M Estimate
